Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 32c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($1.56), $0.32 worse than the analyst estimate of ($1.24).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Baird sees Tesla-SpaceX merger within 12 to 18 months